As of September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S carries a market capitalization of 888.98B, placing it among publicly traded companies globally. Its enterprise value stands at 1.03T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 888.98B |
| Enterprise Value | 1.03T |
Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S's next confirmed earnings release is scheduled for January 27, 2027.
| Earnings Date | 1/27/2027 |
As of September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S has 20.82B shares outstanding.
| Shares Outstanding | 20.82B |
These figures are as of September 30, 2026.
| PB Ratio | 3.36 |
| P/TBV Ratio | -142.12 |
As of September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.45 |
| Quick Ratio | 1.00 |
| Debt / Equity | 60.36 |
These figures cover the twelve months ended September 30, 2026.
| Employee Count | 115,000.00 |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S recorded 6.56B in income tax expense.
| Income Tax | 6.56B |
As of the close on November 16, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S's stock has declined approximately 9.51% over the past 52 weeks. The 50-day moving average sits at 45.65, while the 200-day moving average is 43.72.
| 52-Week Price Change | -9.51% |
| 50-Day Moving Average | 45.65 |
| 200-Day Moving Average | 43.72 |
As of September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S holds 22.27B in cash and equivalents against 161.48B in total debt, resulting in a net debt position of 140.48B. Total book value stands at 264.45B, with working capital of 38.06B providing operational flexibility.
| Cash & Cash Equivalents | 22.27B |
| Total Debt | 161.48B |
| Net Debt | 140.48B |
| Equity (Book Value) | 264.45B |
| Book Value Per Share | 12.70 |
| Working Capital | 38.06B |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -8.30B |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S paid dividends of 0.80 per share.
| Dividend Per Share | 0.80 |
Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S's most recent stock split took place on November 24, 2022 with a 1:3 split ratio.
| Last Split Date | 11/24/2022 |
| Split Ratio | 1:3 |